|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 248, Issue 3 292-E298, Copyright © 1985 by American Physiological Society
ARTICLES |
D. E. Rannels, J. L. Addison and A. E. Pegg
Rat lungs perfused in situ were employed to begin investigations of the pathways by which the tissue takes up circulating polyamines (PA). Uptake kinetics were studied using [14C]methylglyoxal bis(guanylhydrazone) (MGBG), a nonmetabolized substrate analogue thought to enter cells via the PA carrier. Lungs concentrated MGBG from the perfusate at a linear rate for at least 60 min. Uptake was saturable with respect to perfusate MGBG concentration; it exhibited an apparent Km of 12.5 microM and Vmax of 0.6 nmol X g lung-1 X min-1. MGBG (1 microM) uptake was inhibited rapidly and to a similar extent (30-40%) by the naturally occurring PAs spermidine, spermine, or putrescine (50 microM); no additional inhibition of uptake was exerted when all three compounds were present simultaneously (total concentration, 150 microM). No inhibition by 5-hydroxytryptamine was evident. Spermidine produced a half-maximal inhibitory effect at a perfusate concentration of 1.9 microM (vs. 1 microM MGBG). The spermidine-insensitive component of MGBG uptake operated at a Vmax similar to that of the control (total), 1.2 nmol X g-1 X min-1, but the apparent Km was increased 3.5-fold to 44 microM. These observations indicate that MGBG is taken up from the pulmonary circulation by a high-affinity, carrier-mediated, concentrative uptake process that is inhibited, at least in part, by naturally occurring polyamines.
This article has been cited by other articles:
![]() |
P. H. M. Hoet and B. Nemery Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions Am J Physiol Lung Cell Mol Physiol, March 1, 2000; 278(3): L417 - L433. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |